Stacks of pills and coins The complexity and cost of the system means that approximately 20% of prescriptions are never filled—leading to long-term health outcomes that carry high costs as well. (Photo: Shutterstock)

The pharmaceutical industry is experiencing an ongoing loop of increasing drug costs due to drug utilization management programs that are a response to higher drug costs, a new study in Health Affairs has found.

The report described an “escalating cycle” that results in $93.3 billion in annual costs—just for drug utilization management. Part of the impetus for this spending is the increasing use of high-priced specialty drugs, the report said. With costs to payers rising, they are implementing more stringent prior authorization and formulary policies, while increasing the cost-sharing burden on patients.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.